Guanylate-binding protein 1 correlates with advanced tumor features, and serves as a prognostic biomarker for worse survival in lung adenocarcinoma patients

Guanylate-binding protein 1 correlates with advanced tumor features, and serves as a prognostic biomarker for worse survival in lung adenocarcinoma patients

Objective: Guanylate-binding protein 1 (GBP1) is reported to promote tumor progression and treatment resistance in lung cancer, and presents as a prognostic biomarker in several solid tumors. However, the related research of GBP1 in clinical management of lung adenocarcinoma is still lacking. Theref...

Full description

Bibliographic Details
Main Authors: Gao, F. (Author), Li, L. (Author), Qu, J. (Author), Wan, Q. (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2021
Subjects:
Adenocarcinoma of Lung
adult
advanced cancer
aged
Aged
Article
Biomarkers, Tumor
cancer patient
cancer prognosis
cancer staging
cancer survival
cancer tissue
carcinoembryonic antigen
clinical feature
controlled study
data analysis
disease free survival
Disease-Free Survival
female
GBP1 protein, human
GTP-Binding Proteins
guanine nucleotide binding protein
guanylate binding protein 1
guanylate-binding protein 1
human
human tissue
Humans
immunohistochemistry
immunohistochemistry assay
lung adenocarcinoma
Lung Neoplasms
lung parenchyma
lung tumor
lymph node metastasis
Lymphatic Metastasis
major clinical study
male
Male
metabolism
middle aged
Middle Aged
mortality
overall survival
pathology
preoperative period
prognosis
Prognosis
protein function
Retrospective Studies
retrospective study
survival
tumor features
tumor marker
tumor volume
unclassified drug
upregulation
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items